Your browser doesn't support javascript.
loading
Investigations of Laser-Assisted Renal Denervation for Treatment of Resistant Hypertension.
Hwang, Junghyun; Shin, Hwarang; Jung, Minwoo; Kang, Hyun Wook.
Afiliación
  • Hwang J; Major of Biomedical Engineering, Division of Smart Healthcare, College of Information Technology and Convergence, Pukyong National University, Busan, Republic of Korea.
  • Shin H; Marine-Integrated Biomedical Technology Center, Pukyong National University, Busan, Republic of Korea.
  • Jung M; Marine-Integrated Biomedical Technology Center, Pukyong National University, Busan, Republic of Korea.
  • Kang HW; Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan, Republic of Korea.
Lasers Surg Med ; 2024 Jul 04.
Article en En | MEDLINE | ID: mdl-38965757
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Renal denervation (RDN) is an emerging surgical treatment for resistant hypertension. However, the current RDN using radiofrequency can cause undesirable thermal damage to the medial and luminal layers due to direct contact between the arterial lumen and energy source. The aim of this study is to evaluate the feasibility of the new laser-assisted RDN by exploring the potential treatment conditions.

METHODS:

For ex vivo testing, six different treatment conditions (10 and 20 W applied for delivery of 300, 450, and 600 J) were tested on the porcine liver and renal artery (RA) by using a continuous wave 1064 nm laser wavelength. The ablated area in the liver tissue was measured to estimate the extent of the coagulated area. Histological evaluation was performed on the treated RA tissues to confirm the extent of thermal nerve damage.

RESULTS:

The ablated depth, length, and area in the liver tissue increased with laser power and total energy. According to the histological results, 20 W groups yielded more significant damage to the RA nerves than 10 W groups at the total energy of 300 J (0.0 ± 0.0 mm for 10 W vs. 2.9 ± 1.0 mm for 20 W), 450 J (1.9 ± 0.6 mm for 10 W vs. 6.8 ± 1.5 mm for 20 W), and 600 J (2.9 ± 0.4 mm for 10 W vs. 7.3 ± 0.8 mm for 20 W). The treated RA exhibited insignificant medial injury in depth (medial thinning ≤ 25%), and no difference in the medial thinning was found among the six groups (p = 0.4).

CONCLUSION:

The current study demonstrated that the 1064 nm laser at 20 W with delivery of 450 J could effectively damage the RA nerves with no or minimal injury to the surrounding tissue. The proposed laser-assisted RDN may enhance physiological effects with insignificant complications in in vivo situations. Further in vivo studies will be conducted to validate the current findings by evaluating the extent of blood pressure reduction and norepinephrine changes after the laser-assisted RDN on a large animal model.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Lasers Surg Med Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Lasers Surg Med Año: 2024 Tipo del documento: Article